Quantitative structure activity relationship of IA3-like peptides as aspartic proteinase inhibitors. 2009

Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
Laboratory of Theoretical and Computational Chemistry, Chemistry Faculty, Havana University, 10400, Havana, Cuba.

The IA(3) polypeptide inhibitor from Saccharomyces cerevisiae interacts potently and selectively with its target, the S. cerevisiae vacuolar aspartic proteinase (ScPr). Upon encountering the enzyme, residues 2-32 of the intrinsically unstructured IA(3) polypeptide become ordered into an almost-perfect alpha-helix. In previous IA(3) mutagenesis studies, we identified important characteristics of the enzyme inhibitor interactions and generated a large dataset of variants with K(i) values determined experimentally at pH 3.1 and 4.7. Using this information, the three-dimensional structure of each variant was modelled in silico with the correct protonation for each experimental pH value. A set of descriptors of the inhibitor/ScPr interactions was then calculated and used to establish mathematical models relating the variant sequences to their inhibitory activities at each pH. Cross-validation, external-set validation and five separate selections of the training and test samples confirmed the robustness of the equations. A major contributor to the structure-activity relationship was the free energy of binding calculated by the FoldX program. The mathematical models were challenged further (i) by in silico alanine-scanning mutagenesis of residues 2-32 in IA(3) and relating binding energy to experimentally derived inhibition constants for selected representatives of these variants; and (ii) by predicting inhibitory-potencies for two novel IA(3)-variants. The predictions of the equations for these new IA(3)-variants with ScPr matched almost precisely the kinetic data determined experimentally. The models described represent valuable tools for the future design of novel inhibitor variants active against ScPr and other aspartic proteinases.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker

Related Publications

Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
February 2016, Toxins,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
January 1981, Acta biologica et medica Germanica,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
April 2004, Biochemistry,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
December 2006, Journal of agricultural and food chemistry,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
January 2005, Journal of medicinal chemistry,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
November 1985, The Biochemical journal,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
June 2021, Journal of chemical information and modeling,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
January 1991, Advances in experimental medicine and biology,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
July 2007, The FEBS journal,
Juan Alexander Padrón-García, and Manuel Alonso-Tarajano, and Esther Alonso-Becerra, and Tim J Winterburn, and Yasser Ruiz, and John Kay, and Colin Berry
March 2007, The Journal of biological chemistry,
Copied contents to your clipboard!